- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Tuesday, 15 December 2009
-
Current Status:
Answered by Shona Robison on 12 January 2010
To ask the Scottish Executive, further to the answer to question S3W-28899 by Shona Robison on 19 November 2009, whether all local authorities have confirmed that their local arrangements for access to social care services and timescales for access to personal and nursing care services are compatible with the national definitions and standards set out in the guidance, National Standard Eligibility Criteria and Waiting Times for the Personal and Nursing Care of Older People.
Answer
Yes. All 32 local authorities have confirmed that their local arrangements for access to social care services and timescales for access to personal and nursing care services are consistent with the guidance.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Thursday, 10 December 2009
-
Current Status:
Answered by Nicola Sturgeon on 12 January 2010
To ask the Scottish Executive whether primary school children with asthma are in the priority category for the influenza A (H1N1) vaccination programme and, if so, for what reason some of them have not yet been invited for vaccination.
Answer
The at risk groups as announced on 13 August 2009 includes all people who have asthma that requires continuous or repeated use of systematic steroids or with previous exacerbations requiring hospital admission.
The H1N1 vaccination programme was launched on 21 October and proceeded with a phased roll out from this date. Health boards have indicated that vaccination has been offered to all those in the initial priority groups and a mop up exercise continues to take place to the end of January to ensure that everyone in the initial priority groups has been invited for vaccination.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Thursday, 10 December 2009
-
Current Status:
Answered by Nicola Sturgeon on 12 January 2010
To ask the Scottish Executive how many health and social care workers have been (a) invited to have the influenza A (H1N1) vaccination and (b) vaccinated.
Answer
Health boards have indicated that vaccination has been offered to all those in the initial priority groups, including health and social care workers. A mop up exercise continues to take place to the end of January however, to ensure that everyone in the initial priority groups has been invited for vaccination.
To date, 50.8% of eligible frontline health care staff have received the vaccination and 32.1% of eligible frontline social care staff have been vaccinated.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Thursday, 10 December 2009
-
Current Status:
Answered by Nicola Sturgeon on 12 January 2010
To ask the Scottish Executive, further to the answer to question S3W-28625 by Nicola Sturgeon on 16 November 2009, how many doses of the influenza A (H1N1) vaccine have been delivered to (a) NHS boards and (b) GP practices in each week since 21 October 2009.
Answer
NHS Scotland has now received 100% of the vaccine supply required to vaccinate all those in the initial priority groups and all children aged over six months and under five years. This means that 1,716,500 doses of pandemrix and 167,800 doses of celvapan have been delivered to health boards and GP practices across Scotland.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Thursday, 10 December 2009
-
Current Status:
Answered by Nicola Sturgeon on 12 January 2010
To ask the Scottish Executive, further to the answer to question S3W-28625 by Nicola Sturgeon on 16 November 2009, how many of the 1.3 million people in the priority groups for the influenza A (H1N1) vaccination programme have been vaccinated.
Answer
Health boards have indicated that vaccination has been offered to all those in the initial priority groups. Data for patients in the clinical priority groups estimate that the uptake rate for vaccination to date equates to 45.6% for all clinical at risk groups.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Wednesday, 09 December 2009
-
Current Status:
Answered by Nicola Sturgeon on 11 January 2010
To ask the Scottish Executive how many patients diagnosed with Guillain-Barré syndrome following an influenza A (H1N1) vaccination (a) have recovered and been discharged and (b) remain in hospital.
Answer
The Medicines and Healthcare Regulatory Agency (MHRA) monitor all reports of side effects and publish weekly reports outlining these cases. There have been two suspected cases of Guillain-Barr© syndrome (GBS) reported in the UK to-date following H1N1 vaccination. Further information is awaited in order to fully assess diagnostic certainty. There is no evidence across Europe of any vaccine associated risk of GBS.
The current condition of the two patients is unknown, however these cases were reported as not fatal. Eight in 10 people with GBS make a full recovery within a few weeks or months. One in 10 people become wheelchair-bound, or have permanent weakness or numbness. There is a 5% mortality rate from GBS.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Wednesday, 09 December 2009
-
Current Status:
Answered by Nicola Sturgeon on 11 January 2010
To ask the Scottish Executive whether there has been an increase in the number of cases of Guillain-Barré syndrome and, if so, what the reason is for this.
Answer
Guillain-Barr© Syndrome (GBS) affects approximately 1,500 people in the UK every year. The trend in the number of new cases of GBS diagnosed in Scotland does not show a statistically significant increase between 1999 and 2008. Complete data for 2009 is not yet available.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Wednesday, 09 December 2009
-
Current Status:
Answered by Nicola Sturgeon on 11 January 2010
To ask the Scottish Executive how many cases of Guillain-Barré syndrome have been diagnosed in each year since 2007.
Answer
The number of new cases of Guillain-Barr© syndrome (GBS) diagnosed in acute hospital care in Scotland in the last 10 years is as follows. Information on the number of cases of GBS is only available until year ending 2008.
| 1999 | 92 |
| 2000 | 99 |
| 2001 | 86 |
| 2002 | 95 |
| 2003 | 97 |
| 2004 | 111 |
| 2005 | 71 |
| 2006 | 88 |
| 2007 | 110 |
| 2008 | 109 |
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Wednesday, 09 December 2009
-
Current Status:
Answered by Nicola Sturgeon on 11 January 2010
To ask the Scottish Executive what the symptoms are of Guillain-Barré syndrome.
Answer
Guillain-Barr© syndrome (GBS) usually develops quickly, over a few days, but can sometimes develop gradually over a period of up to four weeks. Symptoms first appear one to three weeks after a minor infection, such as a cold or sore throat.
Initial symptoms tend to start in the feet and hands and include tingling, numbness, unsteadiness and progressive muscle weakness. These symptoms soon spread up the limbs, affecting the legs and arms a few days later. Some people only have a mild form of the condition and their symptoms do not get any worse than a general feeling of weakness.
In some cases, the muscle weakness progresses to temporary paralysis of the legs, arms and face, temporary paralysis of the respiratory muscles that control breathing, difficulty with eye movement and speech, difficulty with chewing or swallowing, difficulty with bladder control or digestion and slow heart rate or low blood pressure.
The extent of paralysis varies with each case of GBS but the most serious cases can paralyse respiratory muscles and stop the patient from breathing.
- Asked by: Jackie Baillie, MSP for Dumbarton, Scottish Labour
-
Date lodged: Wednesday, 09 December 2009
-
Current Status:
Answered by Nicola Sturgeon on 11 January 2010
To ask the Scottish Executive how many cases of Guillain-Barré syndrome following an influenza A (H1N1) vaccination have been diagnosed since October 2009, broken down by NHS board.
Answer
Two cases of suspected Guillain-Barr© syndrome (GBS) have been reported to the Medicines and Healthcare products Regulatory Agency (MHRA), following H1N1 vaccination in the UK to date. There is no evidence across Europe of any vaccine-associated GBS. GBS is a naturally occurring condition and it is inevitable that cases will occur not long after vaccination, without the vaccine playing a role. This is particularly so over the winter period when pathogens that may cause GBS are circulating.
The MHRA does not provide information on the location of these cases, given the very small numbers may mean that individuals could be identified.